WELLBUTRIN XL
Pronunciation: byoo-PROE-pee-on (WEL-byoo-trin)


What it isBupropion extended-release (WELLBUTRIN XL, 2003) inhibits norepinephrine and dopamine reuptake; depression and seasonal affective disorder.
Why this oneTaken once daily, it is the only antidepressant with a seasonal-affective-disorder indication (2006) while retaining an activating, sexually sparing profile.
What limits itSeizure risk and insomnia limit it; avoid in eating or seizure disorders. Strong CYP2D6 inhibition drives interactions.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Major depressive disorder | Adults | 150 mg QAM | 300 mg QD | 300 mg QD |
| Prevention of seasonal affective disorder | Adults | 150 mg QAM | 300 mg QD | 300 mg QD |
Titration MDD: after 4 days may increase to 300 mg QD; SAD: after 7 days may increase to 300 mg QD
Renal Reduce dose and/or frequency (GFR <90 mL/min)
Hepatic Moderate–severe (Child-Pugh 7–15): max 150 mg every other day; mild: reduce dose/frequency
Available strengths
Pregnancy First-trimester epidemiologic data show no increased risk of congenital malformations overall
Lactation Bupropion and metabolites present in human milk; seizures reported in breastfed infants
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 150 mg | ER tab | 30 qd | $2.35 | offered |
| 300 mg | ER tab | 30 qd | $3.01 | offered |
Other forms: Bupropion (WELLBUTRIN) · Bupropion hydrobromide ER (APLENZIN) · Bupropion SR (WELLBUTRIN SR) · Bupropion XL 450 mg (FORFIVO XL)
Available combined with: dextromethorphan / bupropion · naltrexone / bupropion
⚠ BOXED WARNING
Legacy pregnancy categoryC
Defining liabilityDose-related seizures and delayed cardiotoxicity are prominent in overdose, especially with extended-release products.
Open Bupropion XL in the interactive console ↗